{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3673, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-341d-707d-8f10-e094a3d9771c", "docSlug": "c0c2a81b97260bf20014943df2470872", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a sequential clinical trial process.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/33", "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c", "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-341d-707d-8f10-e094a3d9771c", "docSlug": "c0c2a81b97260bf20014943df2470872", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/34", "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c", "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-341d-707d-8f10-e094a3d9771c", "docSlug": "c0c2a81b97260bf20014943df2470872", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "team_bio", "function": "other", "notes": "The slide highlights the team's pedigree by listing past company affiliations for each executive and providing a collective logo grid at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/35", "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c", "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 35, "from": 35, "beatId": "493482e1-fe58-4e6b-904e-a76e5407321c", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The team is introduced on page 35.", "position": 4, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-341d-707d-8f10-e094a3d9771c", "docSlug": "c0c2a81b97260bf20014943df2470872", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix", "function": "other", "notes": "The slide uses a timeline framework to map patent coverage and exclusivity periods across two main product categories.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/36", "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c", "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-341d-707d-8f10-e094a3d9771c", "docSlug": "c0c2a81b97260bf20014943df2470872", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "appendix_data", "function": "summarize", "notes": "The slide provides a snapshot of the company's financial health as of late 2023.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/37", "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c", "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-341d-707d-8f10-e094a3d9771c", "docSlug": "c0c2a81b97260bf20014943df2470872", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a grouped list format to present clinical trial milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/38", "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c", "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-341d-707d-8f10-e094a3d9771c", "docSlug": "c0c2a81b97260bf20014943df2470872", "documentTitle": "Equillium | Investor Presentation Deck | 39 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-341d-707d-8f10-e094a3d9771c/39", "deckHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c", "deckAnchorHref": "/decks/019de076-341d-707d-8f10-e094a3d9771c#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "The slide uses a high-quality lifestyle photo to establish an emotional connection to the company's mission.", "imagePath": "https://imgproxy.kitesheet.com/_tPgrK_Bubg0Cl3X1kUhvplWefDZEQ2MUrZr4myiR0o/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lN2RhNmM4OWJkMDBlZGZlNWVlMTBmMTIzMzMxNjdmZi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/1", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "38d0ca96-39fe-49b4-b8ae-bc6186fb415b", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Introduction to Erasca and RAS/MAPK pathway", "beatSlug": "rags-to-riches-humble-origins", "evidence": "Slides 1-5 introduce Erasca's mission, team, and market opportunity", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/pVGafVjvfmH1i7SimNGOMoyeD-77fQ00u5FNCymf1GY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lN2RhNmM4OWJkMDBlZGZlNWVlMTBmMTIzMzMxNjdmZi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/foEkZE3voArwZUdagShOmfjb7OG7rqYVTbYbe6XYWE8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lN2RhNmM4OWJkMDBlZGZlNWVlMTBmMTIzMzMxNjdmZi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/6rNR6ztYVfOG1e4ov5YZxso-Z5caY6BP9sO6EC8mS8Y/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9lN2RhNmM4OWJkMDBlZGZlNWVlMTBmMTIzMzMxNjdmZi9wMDAxLnBuZw" }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/2", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "38d0ca96-39fe-49b4-b8ae-bc6186fb415b", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Introduction to Erasca and RAS/MAPK pathway", "beatSlug": "rags-to-riches-humble-origins", "evidence": "Slides 1-5 introduce Erasca's mission, team, and market opportunity", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "mission", "function": "inspire_vision", "notes": "The slide uses a hub-and-spoke diagram to connect the company name to three core pillars: leadership, portfolio, and financials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/3", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "38d0ca96-39fe-49b4-b8ae-bc6186fb415b", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Introduction to Erasca and RAS/MAPK pathway", "beatSlug": "rags-to-riches-humble-origins", "evidence": "Slides 1-5 introduce Erasca's mission, team, and market opportunity", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "team_bio", "function": "other", "notes": "SAB stands for Scientific Advisory Board.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/4", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "38d0ca96-39fe-49b4-b8ae-bc6186fb415b", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Introduction to Erasca and RAS/MAPK pathway", "beatSlug": "rags-to-riches-humble-origins", "evidence": "Slides 1-5 introduce Erasca's mission, team, and market opportunity", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The table uses a heatmap-style color coding where red indicates existing targeted therapy markets and teal indicates blue ocean opportunities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/5", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-5", "loopMatches": [ { "to": 10, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3", "evidence": "Slides 5-10 introduce the pathway and pipeline", "position": 0, "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "38d0ca96-39fe-49b4-b8ae-bc6186fb415b", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Introduction to Erasca and RAS/MAPK pathway", "beatSlug": "rags-to-riches-humble-origins", "evidence": "Slides 1-5 introduce Erasca's mission, team, and market opportunity", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for the company's therapeutic approach.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/6", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-6", "loopMatches": [ { "to": 10, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3", "evidence": "Slides 5-10 introduce the pathway and pipeline", "position": 0, "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Challenges in current cancer treatment and unmet needs", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization for clinical trial progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/7", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-7", "loopMatches": [ { "to": 10, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3", "evidence": "Slides 5-10 introduce the pathway and pipeline", "position": 0, "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Challenges in current cancer treatment and unmet needs", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a biological process diagram to map drug assets to specific protein targets.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/8", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-8", "loopMatches": [ { "to": 10, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3", "evidence": "Slides 5-10 introduce the pathway and pipeline", "position": 0, "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Challenges in current cancer treatment and unmet needs", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a matrix structure to map indications to benchmarks, specific drug regimens, and trial names, with a footer detailing active clinical trial collaboration and supply agreements (CTCSAs).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/9", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-9", "loopMatches": [ { "to": 10, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3", "evidence": "Slides 5-10 introduce the pathway and pipeline", "position": 0, "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Challenges in current cancer treatment and unmet needs", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The chart uses a stacked bar approach to represent US and Europe patient counts per program, with a total sum at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/10", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-10", "loopMatches": [ { "to": 10, "from": 5, "name": "Logic Chain", "slug": "01-logic-chain", "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis", "matchId": "35467dbb-a048-4577-a17f-95d4c07fd9a3", "evidence": "Slides 5-10 introduce the pathway and pipeline", "position": 0, "objective": "Introduce RAS/MAPK pathway and Erasca's pipeline", "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)", "confidence": 0.7, "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion" } ], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Challenges in current cancer treatment and unmet needs", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide combines a biological pathway diagram (left) with a quantitative market sizing table (right).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/11", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Challenges in current cancer treatment and unmet needs", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "solution", "function": "present_solution", "notes": "The kinome tree is a standard visualization for kinase selectivity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/12", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Challenges in current cancer treatment and unmet needs", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "traction", "function": "show_traction", "notes": "The slide combines a biological pathway diagram with a clinical trial summary table to demonstrate proof of concept.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/13", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Challenges in current cancer treatment and unmet needs", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "traction", "function": "show_traction", "notes": "Includes two waterfall plots comparing patient responses; source cited as Novartis materials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/14", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Challenges in current cancer treatment and unmet needs", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/15", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-15", "loopMatches": [ { "to": 20, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f", "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline", "position": 1, "objective": "Highlight the cost of not addressing unmet needs in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 15, "from": 6, "beatId": "dba801b5-a4b0-4e64-a12d-ace71b366d55", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Challenges in current cancer treatment and unmet needs", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Slides 6-15 discuss current treatment limitations and unmet needs in cancer", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "Waterfall plot shows individual patient responses; table compares efficacy metrics against Dacarbazine and Binimetinib.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/16", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-16", "loopMatches": [ { "to": 20, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f", "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline", "position": 1, "objective": "Highlight the cost of not addressing unmet needs in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "testimonial", "function": "illustrate_case", "notes": "The slide uses a before-after-framing approach to demonstrate clinical efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/17", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-17", "loopMatches": [ { "to": 20, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f", "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline", "position": 1, "objective": "Highlight the cost of not addressing unmet needs in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a swimmer plot to visualize individual patient treatment duration and response status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/18", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-18", "loopMatches": [ { "to": 20, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f", "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline", "position": 1, "objective": "Highlight the cost of not addressing unmet needs in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a summary calculation (13/39 = 33.3% ORR) to aggregate results across two different clinical phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/19", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-19", "loopMatches": [ { "to": 20, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f", "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline", "position": 1, "objective": "Highlight the cost of not addressing unmet needs in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "traction", "function": "show_traction", "notes": "Swimmer plot showing individual patient treatment duration and response status (NE, PD, PR, SD).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/20", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-20", "loopMatches": [ { "to": 20, "from": 15, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "843a34f0-1c93-40b5-8e7f-36476533a31f", "evidence": "Slides 15-20 discuss current treatment limitations and potential for Erasca's pipeline", "position": 1, "objective": "Highlight the cost of not addressing unmet needs in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The diagram uses a flow-chart structure to categorize patient outcomes (off treatment vs on treatment) and further breaks down the 'on treatment' group into SDs and PRs with specific progression delay metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/21", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "traction", "function": "analyze_data", "notes": "The chart displays adverse events occurring in >=10% of patients (n=15).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/22", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "roadmap", "function": "plan_implementation", "notes": "CoC = Cost of Care (or standard of care context); FIH = First-in-Human; PTS = Probability of Technical Success; CDP = Clinical Development Plan.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/23", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a biological signaling pathway map to justify combination therapy strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/24", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The diagram shows the RAS/MAPK signaling pathway. The table provides a breakdown of patient populations for specific indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/25", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "solution", "function": "present_solution", "notes": "The slide uses two tables to demonstrate competitive advantage in potency and pharmacokinetics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/26", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "solution", "function": "present_solution", "notes": "The diagram shows the signaling pathway with specific drug targets highlighted.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/27", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "traction", "function": "show_traction", "notes": "The slide compares tumor volume reduction across two different CDX models (WiDr and RKO) using various treatment regimens.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/28", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "traction", "function": "show_traction", "notes": "Includes waterfall plot and swimmer plot for clinical trial results.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/29", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data cut 23MAR2023. TRAE = Treatment-related Adverse Event. EC = Encorafenib + Cetuximab.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/30", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-30", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a process-oriented flow to demonstrate clinical validation milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/31", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-31", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide highlights selectivity and potency, using arrows to indicate performance relative to the competitor.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/32", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-32", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "traction", "function": "show_traction", "notes": "Data presented as tumor volume over time (days) with error bars representing SEM.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/33", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-33", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "testimonial", "function": "illustrate_case", "notes": "Includes RECIST 1.1 criteria reference and specific patient history.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/34", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-34", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table compares 'ALL' vs 'Gr >= 3' adverse events for different dosing regimens.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/35", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-35", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The diagram shows the EGFR signaling pathway and the inhibitory effect of ERAS-801.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/36", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-36", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a stacked bar chart to show mutation incidence and a comparison table to contrast clinical outcomes across different indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/37", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-37", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "solution", "function": "present_solution", "notes": "The slide uses Western blot data to demonstrate potency and a table to demonstrate pharmacokinetic superiority.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/38", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-38", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "solution", "function": "present_solution", "notes": "The chart is a Kaplan-Meier survival plot. The comparison shows ERAS-801 (blue line) outperforming standard EGFR inhibitors (Erlotinib, Lapatinib, Osimertinib) and vehicle control.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/39", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "traction", "function": "show_traction", "notes": "The slide displays four distinct survival plots (HK301, GS025, HK336, GS187) showing statistically significant survival improvements (***) with ERAS-801 treatment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/40", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-40", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a waterfall plot to show individual model responses and pie charts to summarize efficacy across the total cohort vs. the specific EGFR-mutant/amplified subset.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/41", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-41", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a table format to communicate a product roadmap for clinical development.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/42", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-42", "loopMatches": [], "arcBeatMatches": [ { "to": 42, "from": 16, "beatId": "de59f7d9-38c9-46a9-8877-a3655888462f", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Erasca's pipeline and clinical data", "beatSlug": "rags-to-riches-rising-success", "evidence": "Slides 16-42 present Erasca's pipeline and clinical data", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/43", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-43", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 43, "beatId": "208ecfc2-9d23-4d32-944a-1372c9b19645", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Potential impact and investment thesis", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "Slides 43-44 present the investment thesis and potential impact", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "closing_ask", "function": "summarize", "notes": "Features the Erasca logo and a Lorenz attractor-style graphic.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/44", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-44", "loopMatches": [], "arcBeatMatches": [ { "to": 44, "from": 43, "beatId": "208ecfc2-9d23-4d32-944a-1372c9b19645", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Potential impact and investment thesis", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "Slides 43-44 present the investment thesis and potential impact", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a matrix-like layout to compare drug candidates by development stage and company, with a callout box for competitive advantages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/45", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-45", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "roadmap", "function": "prioritize", "notes": "The slide uses a bullseye/concentric circle framework to communicate strategic prioritization of clinical trials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/46", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-46", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a contrast-based layout to frame the subject as a winner in a difficult therapeutic space.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/47", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-47", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "solution", "function": "present_solution", "notes": "The slide uses western blot data to demonstrate the superiority of ERAS-007 in a specific biological pathway context.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/48", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-48", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 49, "slideType": "other", "function": "illustrate_case", "notes": "Includes RECIST 1.1 criteria reference and patient progression note.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/49", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-49", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 50, "slideType": "traction", "function": "show_traction", "notes": "The chart displays individual patient responses to treatment, with bars colored by dosage level.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/50", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-50", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 51, "slideType": "traction", "function": "show_traction", "notes": "The chart displays individual patient treatment timelines, with markers for partial response, stable disease, and progressive disease.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/51", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-51", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 52, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data from HERKULES-1 study, cutoff 23 May 2022.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-34c7-7046-ba4a-b568cf89a7c9/52", "deckHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9", "deckAnchorHref": "/decks/019de076-34c7-7046-ba4a-b568cf89a7c9#slide-52", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-34c7-7046-ba4a-b568cf89a7c9", "docSlug": "e7da6c89bd00edfe5ee10f12333167ff", "documentTitle": "Erasca | Investor Presentation Deck | 56 slides", "authorId": "erasca", "authorName": "Erasca", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 53, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a line chart to show concentration over time and a table to summarize key PK metrics (Cmax, Cmin, T>IC90, T